Phase 1 Paclitaxel Clinical Trials

2 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–2 of 2 trials

Recruiting

Phase 1Phase 2

A Phase I/II Study of Intraperitoneal Paclitaxel in Patients With Metastatic Appendiceal Adenocarcinoma

Metastatic Appendiceal AdenocarcinomaIntraperitoneal Paclitaxel

M.D. Anderson Cancer Center39 enrolled1 locationNCT06207305

Completed

Phase 1

Oral Paclitaxel for the Treatment of Cancer

Cancer requiring treatment with intravenous paclitaxel

Kinex Pharmaceuticals Inc40 enrolled6 locationsACTRN12615000894594